Arcutis Biotherapeutics ARQT 深 滬
等待開盤 09-20 09:30:00 美东时间
10.14
-0.260
-2.50%
華盛通- 最 高11.18
- 今 開10.69
- 成交量 440.18万股
- 最 低 10.04
- 昨 收 10.40
- 總市值 11.46亿
- 52周最高 13.17
- 市盈率 靜 --
- 換手率 3.90%
- 52周最低 1.76
- 委 比 74.55%
- 總股本 1.13亿
- 歷史最高 40.88
- 量 比 2.56
- 振 幅 10.96%
- 歷史最低 1.76
- 每 手 1
- 風險率 3.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
ARQ-255 is a topical Janus kinase 1 (JAK1) inhibitor suspension formulated as a...
09-05 20:00
Assessing Arcutis Biotherapeutics: Insights From 4 Financial Analysts
Across the recent three months, 4 analysts have shared their insights on Arcuti...
08-28 21:00
快讯 | Arcutis生物治疗公司 - 在治疗56周期间未观察到新的安全信号
Arcutis Biotherapeutics Inc -No New Safety Signals Observed During 56 Weeks of ...
08-28 20:02
快讯 | Arcutis Biotherapeutics公司将在2025年第一季度向美国FDA提交关于罗氟米拉斯膏0.05%的补充新药申请（SNDA）。
Arcutis Biotherapeutics Inc: To Submit Snda to U.S. FDA in Q1 2025 for Roflumil...
08-28 20:01
Arcutis surges 18% as Mizuho highlights growth of Zoryve
Arcutis Biotherapeutics (NASDAQ:ARQT) is up ~18% in Friday trading after Mizuho issued a bullish note citing growth in prescriptions of the company's Zoryve (roflumilast) cream and foam for various sk...
08-24 01:36
Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
08-15 20:11
Arcutis Biotherapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-15 18:33
快讯 | arcutis biotherapeutics二季度业绩公布后盘前下跌1.6%
Arcutis Biotherapeutics Shares Down 1.6% Premarket After Q2 Results
08-15 18:25
Arcutis Biotherapeutics Q2 2024 GAAP EPS $(0.42) Beats $(0.51) Estimate, Sales $30.86M Beat $27.73M Estimate
Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.51) by 17.65 percent. This is a 63.79 percent increase over losses of $(1.16) per
08-15 04:01
快讯 | arcutis biotherapeutics第二季度营业收入为美元指数-5007.7万，低于IBES估计的美元指数-5300万。
Arcutis Biotherapeutics Q2 Operating Income USD -50.077 Million Vs. IBES Estima...
08-15 04:00
